ICD-10-CM Billable Code

T44.5X2

Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm

Clinical Classification Guidelines

Medical Intelligence & Overview

Poisoning by predominantly beta-adrenoreceptor agonists refers to a condition caused by the deliberate intake or exposure to medications that primarily activate beta-adrenergic receptors in the body. These medications are often used to treat respiratory conditions like asthma or chronic obstructive pulmonary disease, but in cases of intentional self-harm, they can cause severe health complications. Recognizing the symptoms and understanding the causes are crucial for appropriate intervention and management.

Causes & Symptoms

Clinical Causes: Intentional overdose of medications containing beta-adrenoreceptor agonists, often as a form of self-harm or suicide attempt. Misuse of these medications without medical guidance, leading to unintentional poisoning. Accidental ingestion, especially in environments where multiple medications are stored together or in pediatric cases.

Key Symptoms: Rapid heartbeat (tachycardia) High blood pressure (hypertension) Palpitations or irregular heartbeat Nervousness, restlessness, or anxiety Hand tremors Nausea and vomiting Sweating or cold, clammy skin Difficulty breathing or shortness of breath Dizziness or lightheadedness In severe cases, chest pain or even loss of consciousness

Diagnostic & Treatment

Diagnosis Path: Diagnosis is primarily based on a comprehensive medical history, including information about suspected or known ingestion of beta-adrenergic agonists. Physical examination focusing on cardiovascular and respiratory systems is essential. Blood tests can confirm the presence of the medication, and additional laboratory tests may evaluate organ function. Healthcare providers might also utilize toxicology screens to identify specific substances involved.

Treatment Protocols: Treatment strategies center around stabilizing the patient's vital signs and managing symptoms. This may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T44.5X2 a billable ICD-10 code?
Yes, T44.5X2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T44.5X2?
Clinical documentation must specify the nature of Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm and any associated comorbidities for accurate reporting.

Cite this Clinical Reference